Form 8-K - Current report:
SEC Accession No. 0001279569-23-001516
Filing Date
2023-12-01
Accepted
2023-12-01 08:02:03
Documents
12
Period of Report
2023-11-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm   iXBRL 8-K 29504
  Complete submission text file 0001279569-23-001516.txt   200157

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ffntf-20231130.xsd EX-101.SCH 3036
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ffntf-20231130_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ffntf-20231130_pre.xml EX-101.PRE 22372
6 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 3165
Mailing Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054
Business Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054 (602) 633-3067
4Front Ventures Corp. (Filer) CIK: 0001783875 (see all company filings)

EIN.: 834168417 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56075 | Film No.: 231457560
SIC: 2833 Medicinal Chemicals & Botanical Products